Venn Life Sciences Holdings PLC Result of AGM (4268K)

TIDMVENN

RNS Number : 4268K

Venn Life Sciences Holdings PLC

24 June 2014

Venn Life Sciences Holdings Plc

Result of AGM

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that at its Annual General Meeting held earlier today, 24 June 2014, all resolutions were duly passed.

Enquiries:

 
 Venn Life Sciences Holdings Plc                         www.vennlifesciences.com 
 Tony Richardson, Chief Executive                            Tel: +353 154 99 341 
  Officer 
 Orla McGuinness, Marketing Manager                     Tel: +33 (0)1 30 82 67 07 
 
 Zeus Capital (Nominated Adviser 
  and Broker) 
 Ross Andrews/Andrew Jones (Corporate                          Tel: 0161 831 1512 
  Finance) 
 Dominic Wilson (Institutional                                 Tel: 020 7533 7727 
  Sales) 
 
 Walbrook PR Ltd                        Tel: 020 7933 8787 or venn@walbrookpr.com 
 Paul McManus                                                  Mob: 07980 541 893 
 Lianne Cawthorne                                              Mob: 07584 391 303

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management solutions and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK and Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - InnoVenn - focused primarily on breakthrough development opportunities in Skin Science.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGUSSSRSOANUAR

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024